A STUDY OF EFFICACY OF LURASIDONE IN PATIENTS SUFFERING FROM SCHIZOPHRENIA AND RELATED DISORDERS
Journal Title: Journal of Advanced Medical and Dental Sciences Research - Year 2017, Vol 5, Issue 3
Abstract
Background: Persistent symptoms, or experience side effects are associated with many outpatients with schizophrenia or schizoaffective disorder, associated with their current maintenance antipsychotic. Treatment strategies include dose adjustments, addition of adjunctive medications, or allowing the passage of time in the hopes of achieving further symptom reduction and the diminution of adverse effects. Hence; we planned the present study to assess the efficacy of Lurasidone in Patients Suffering from Schizophrenia and Related Disorders. Materials & methods: 30 adult patients diagnosed as suffering from schizophrenia and related disorders (Psychosis NOS) according to DSM 5 were administered Tablet Lurasidone - a new atypical anti-psychotic medicine. The patients were evaluated at day 0, 20, 50 and 80 days of the Study in an open clinical trial. The efficacy and side effects of drugs were assessed with the help of Brief Psychiatric Rating Scale, The Schizophrenia Cognition Rating Scale, Clinical Global Impression Scale, Dosage and Treatment Emergent Scale and Abnormal Involuntary Movement Scale. Laboratory investigations were also done in each patient before and after the study. The dosage ranged from 40 mg – 80 mg daily, the majority being on 80mg/day. All the results were compiled and analyzed by SPSS software. Results: There was statistically significant clinical improvement measured on Severity of Illness sub-scale, at day 20, 50 and 80 in comparison with that at day 0. The same was true for Brief Psychiatric Rating Scale and its three sub-scales- The Depression Sub-Scale, Thinking Disorder Sub-scale and Anergia Sub-Scale. 2 patients didn't complete the study. There was significant improvement on Schizophrenia Cognition Rating Scale on day 20, 50 and 80 in comparison to day 0. Akathesia was the main side effect requiring reduction of dosage or switch to another anti- psychotic. None of the patients showed any abnormal involuntary movements. Conclusion: Lurasidone is an effective and useful drug for the treatment of schizophrenia and related disorders.
Authors and Affiliations
V. P. Mahla, Abhishek Kapoor, Avisha Mahla, Rahul Rai
Keywords
Related Articles
- EP ID EP557787
- DOI -
- Views 106
- Downloads 0
Assessment of Patient’s Attitude towards Dental Implants
Introduction: Replacement of missing or lost teeth with dental prostheses supported by oral implants has been accepted and received positive evaluations from patients who have undergone implant treatment. In spite of thi...
Oral Health Awareness and Practices among Interns in Rewa, Madhya Pradesh
Aim: To assess the oral health awareness and practices of interns in Rewa, Madhya Pradesh. Methods: A cross sectional descriptive study was conducted among the 67 interns posted in Medical College, Rewa during April 201...
Different Surgical Approaches for the Treatment of Gingival Overgrowth of Inflammatory Origin not Amenable to Non-surgical Periodontal Therapy – A Case Series
Inflammatory gingival overgrowth or enlargement is the most common type of gingival overgrowth seen mostly associated with the presence of local factors that predispose to it. The treatment of such enlargement is necessa...
Keratinizing Dentigerous Cyst: A Review of Literature
A dentigerous cyst is a developmental cyst of odontogenic origin which develops around the fully-formed crown of an unerupted tooth. The significance of keratinization in odontogenic cysts is not fully known, but keratin...
Comparative Evaluation of Efficacy of Dexmedetomidine and Propofol for Sedation in Patients Undergoing Gastrointestinal Endoscopy
Background: Gastrointestinal Endoscopy is performed as diagnostic and therapeutic procedure. Data from a recent meta-analysis suggest that propofol sedation is not associated with an increased risk of complications. Dexm...